Regarding the molecular features, the MGMT methylation status positively influenced the prognosis only in patients younger than 54 years with an EOR higher than 96%, thus suggesting the possibility of other genetic abnormalities potentially affecting survivals of GBM patients. Here, MGMT is linked to glioblastoma.